DENTSPLY SIRONA Inc. (XRAY)

NASDAQ: XRAY · USD

$9.43

+0.08 (+0.9%)· Recorded snapshot

Market cap	1.9B
Revenue (ttm)	3.6B
Net income (ttm)	-546M
EPS (ttm)	-$2.73
Shares out	199.4M
P/E (forward)	6.4x
Dividend	$0.16 (1.69%)
Volume	3,008,479
Beta	0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.6B
Net income (ttm): -546M
EPS (ttm): -$2.73
P/E (forward): 6.4x
Market cap: 1.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E6.4

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-33

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XRAY indicators

Market & fundamental data

Available fields

266

Groups with data

Currency

USD

Showing 266 of 266 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000818479
Company name	DENTSPLY SIRONA Inc.
Country	United States
Country code	US
CUSIP number	24906P109
Earnings date	2026-11-05
Earnings time	amc
Employees	14,000
Employees change	-1,000
Employees growth	-6.67%
Enterprise value	$4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1899
In index	RUSSELL2000
Industry	Medical Instruments & Supplies
IPO date	1987-08-12
Is primary listing	Yes
Is SPAC	No
ISIN number	US24906P1093
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2006-07-18
Last stock split type	Forward
Market cap	$1.9B
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$9.43
Price currency	USD
Sector	Healthcare
SIC code	3843
Stock price date	2026-10-28
Symbol	XRAY
U.S. state	North Carolina
Website	https://www.dentsplysirona.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	6.59x
Earnings yield	-28.99%
EV/EBIT	22.46x
EV/EBITDA	7.56x
EV/FCF	27.8x
EV/Sales	1.09x
FCF / EV yield	3.6%
FCF yield	7.57%
Forward EV/Sales	1.11x
Forward P/E	6.44x
Forward P/S	0.53x
Industry forward P/E	22.82x
Industry P/E	66.22x
P/(FCF - SBC) ratio	16.86x
P/(OCF - SBC) ratio	6.56x
P/B ratio	1.38x
P/FCF ratio	13.2x
P/OCF ratio	5.92x
P/S ratio	0.52x
PEG ratio	5.66x
Price/EBITDA ratio	3.59x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.86%
EBITDA margin	14.44%
FCF margin	3.93%
Gross margin	49.52%
Operating margin	4.86%
Pretax margin	-9.53%
Profit margin	-14.99%
Profit per employee	$-39,000
Profitable quarters	1
Revenue per employee	$260,214
ROA	1.96%
ROA (5Y)	2.82%
ROCE	4.4%
ROE	-33.03%
ROE (5Y)	-17.64%
ROIC	5.12%
ROIC (5Y)	5.86%
SBC / revenue	0.85%
Tax / revenue	5.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
FCF growth	3.62%
FCF growth (Q)	243.75%
FCF growth 3Y	-10.28%
FCF growth 5Y	-25.76%
Gross profit growth	-5.35%
Gross profit growth (Q)	0.61%
Gross profit growth 3Y	-4.91%
Gross profit growth 5Y	-4.15%
Net income growth quarters	1
Net income growth years	1
OCF growth	12.72%
OCF growth (Q)	106.25%
OCF growth (QoQ)	147.5%
OCF growth 10Y	-3.89%
OCF growth 3Y	-1.52%
OCF growth 5Y	-15.67%
Operating income growth	-37.23%
Operating income growth (Q)	-23.85%
Operating income growth 3Y	-13.97%
Operating income growth 5Y	-22.13%
Revenue growth	-0.76%
Revenue growth (Q)	-4.06%
Revenue growth (QoQ)	2.05%
Revenue growth 10Y	1.58%
Revenue growth 3Y	-2.55%
Revenue growth 5Y	-2.15%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-176M
Depreciation and amortization	$349M
EBIT	$177M
EBITDA	$526M
EPS	$-2.73
FCF per share	$0.72
Financing cash flow	$-265M
Free cash flow	$143M
Free cash flow minus SBC	$112M
Gross profit	$1.8B
Income taxes	$200M
Investing cash flow	$-173M
Net borrowing	$-146M
Net cash flow	$-120M
Net income	$-546M
Operating cash flow minus SBC	$288M
Operating income	$177M
Revenue	$3.6B
Stock-based compensation	$31M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.96
Book value per share	$6.78
Debt / EBITDA	3.83
Debt / equity	1.72
Debt / FCF	16.27
Goodwill	$1.1B
Interest coverage	1.7
Long-term assets	$3.3B
Long-term liabilities	$2.7B
Net cash (debt)	$-2.1B
Net cash / market cap	-110.6%
Net debt / EBITDA	3.97
Net debt / equity	1.55
Net debt / FCF	14.6
Piotroski F-Score	5
Property, plant and equipment	$974M
Shareholders' equity	$1.4B
Tangible book value	$-657M
Tangible book value per share	$-3.30
Total assets	$5.2B
Total cash	$239M
Total debt	$2.3B
Total liabilities	$3.9B
WACC	6.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.65
Current assets	$1.9B
Current liabilities	$1.2B
Current ratio	1.63
Inventory turnover	2.74
Net working capital	$736M
Quick ratio	0.72
Working capital	$743M
Working capital turnover	4.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.08%
Dividend growth	0%
Dividend growth (10Y)	8.24%
Dividend growth (3Y)	8.58%
Dividend growth (5Y)	9.86%
Dividend growth years	0
Dividend payment date	2026-01-09
Dividend payment years	32
Dividend per share	$0.16
Dividend yield	1.69%
Ex-dividend date	2025-12-26
FCF payout ratio	22.31%
Last dividend	$0.16
Shareholder yield	1.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-83.11%
10Y return CAGR	-15.1%
10Y total return	-80.53%
150-day SMA	$10.95
15Y price change	-75.71%
15Y return CAGR	-7.97%
15Y total return	-71.22%
1D price change	0.86%
1M price change	0.32%
1M total return	0.32%
1W price change	3.86%
1W total return	3.86%
1Y price change	-27.96%
1Y return CAGR	-26.93%
1Y total return	-26.92%
20-day SMA	$8.84
200-day SMA	$11.36
20Y price change	-70.45%
20Y return CAGR	-4.98%
20Y total return	-63.99%
3M price change	-27.57%
3M total return	-27.57%
3Y price change	-69.18%
3Y return CAGR	-30.68%
3Y total return	-66.7%
50-day SMA	$9.75
50-day SMA vs 200-day SMA	50under200
52-week high	$14.76
52-week high date	2026-02-27
52-week low	$8.32
52-week low date	2026-10-15
5Y price change	-83.3%
5Y return CAGR	-28.61%
5Y total return	-81.45%
6M price change	-21.15%
6M total return	-21.15%
All-time high	$69.54
All-time high date	2021-05-10
All-time low	$0.46
All-time low date	1987-11-12
Average true range (ATR)	$0.34
Average volume	4.6M
Beta (1Y)	0.86
Beta (2Y)	0.65
Beta (5Y)	0.88
Change from 52-week high	-36.09%
Change from 52-week low	13.34%
Change from all-time high	-86.44%
Change from all-time low	1,957.6%
Change from open	0.96%
Day's gap	-0.11%
Dollar volume	$28.4M
High price	$9.48
Low price	$9.30
Monthly RSI	34.4
Open price	$9.34
Position in 52-week range	72.22%
Premarket change	-0.43%
Premarket close	$9.35
Premarket price	$9.31
Premarket volume	5K
Previous close	$9.35
Price vs 150-day SMA	-13.85%
Price vs 20-day SMA	6.72%
Price vs 200-day SMA	-16.97%
Price vs 50-day SMA	-3.3%
Relative volume	0.66
RSI	53.79
Sharpe ratio	-0.5
Sharpe ratio (3Y)	-0.77
Sharpe ratio (5Y)	-0.78
Sortino ratio	-0.6
Sortino ratio (3Y)	-0.9
Sortino ratio (5Y)	-0.9
Volume	3M
Weekly RSI	41.9
YTD price change	-17.5%
YTD total return	-17.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	187.9M
Float percentage	94.24%
Shares change (QoQ)	0.3%
Shares change (YoY)	0.08%
Shares held by insiders	0.49%
Shares held by institutions	109.75%
Shares outstanding	199.4M
Short % of float	15.87%
Short % of shares	14.96%
Short ratio	5.4 days

Deeper analysis on XRAY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XRAY report

Is a complete XRAY research report available?

No complete published report is available for DENTSPLY SIRONA Inc. (XRAY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DENTSPLY SIRONA Inc. (XRAY)

Price

Financial snapshot

Fair-value bridge

Latest news · XRAY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XRAY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on XRAY

Frequently asked questions